Optical coherence tomography in the diagnosis and management of diabetic retinopathy

International Ophthalmology Clinics

Volumn 49, Issue 2, 2009, Pages 61-74

  Keane, Pearse A ^a   Sadda, Srinivas R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL ERROR; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; HUMAN; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITATIVE DIAGNOSIS; QUANTITATIVE DIAGNOSIS; REPRODUCIBILITY; REVIEW; VISUAL ACUITY; ARTICLE; DIFFERENTIAL DIAGNOSIS; INJECTION; LASER COAGULATION; METHODOLOGY; PATHOLOGY; RETINA; TREATMENT OUTCOME; VITRECTOMY; VITREOUS BODY;

GLUCOCORTICOID; TRIAMCINOLONE ACETONIDE;

DIABETIC RETINOPATHY; DIAGNOSIS, DIFFERENTIAL; GLUCOCORTICOIDS; HUMANS; INJECTIONS; LASER COAGULATION; REPRODUCIBILITY OF RESULTS; RETINA; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VITRECTOMY; VITREOUS BODY;

EID: 67650273331     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e31819fd54f     Document Type: Review

References (87)

1. US Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2005. Atlanta, GA: Centers for Disease Control and Prevention; 2005.
2. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414-1431.
3. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178-1181.
4. Mohamed Q, Gillies MC,Wong TY. Management of diabetic retinopathy: a systematic review. JAMA. 2007;298:902-916. (Pubitemid 47311296)
5. Massin P, Girach A, Erginay A, et al. Optical coherence tomography: a key to the future management of patients with diabetic macular oedema. Acta Ophthalmol. 2006;84:466-474. (Pubitemid 44109046)
6. Ashton N. Studies of the retinal capillaries in relation to diabetic and other retinopathies. Br J Ophthalmol. 1963;47:521-538.
7. Cogan DG, Toussaint D, Kuwabara T. Retinal vascular patterns. IV. Diabetic retinopathy. Arch Ophthalmol. 1961;66:366-378.
8. Little HL. Alterations in blood elements in the pathogenesis of diabetic retinopathy. Ophthalmology. 1981;88:647-654. (Pubitemid 11087726)
9. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.
10. Sebag J, McMeel JW. Diabetic retinopathy. Pathogenesis and the role of retinaderived growth factor in angiogenesis. Surv Ophthalmol. 1986;30:377-384.
11. Johnson MW. Etiology and treatment of macular edema. Am J Ophthalmol. 2009;147:11-21.e1.
12. Marmor MF. Mechanisms of fluid accumulation in retinal edema. Doc Ophthalmol. 1999;97:239-249.
13. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology. 1991;98:766-785.
14. Tso MO. Pathology of cystoid macular edema. Ophthalmology. 1982;89:902-915.
15. Fine BS, Brucker AJ. Macular edema and cystoid macular edema. Am J Ophthalmol. 1981;92:466-481.
16. Ozdemir H, Karacorlu M, Karacorlu S. Serous macular detachment in diabetic cystoid macular oedema. Acta Ophthalmol. 2005;83:63-66. (Pubitemid 40326423)
17. Soliman W, Sander B, Jørgensen TM. Enhanced optical coherence patterns of diabetic macular oedema and their correlation with the pathophysiology. Acta Ophthalmol. 2007;85:613-617. (Pubitemid 47316759)
18. Catier A, Tadayoni R, Paques M, et al. Characterization of macular edema from various etiologies by optical coherence tomography. Am J Ophthalmol. 2005;140:200-206. (Pubitemid 41125797)
19. Nasrallah FP, Jalkh AE, Van Coppenolle F, et al. The role of the vitreous in diabetic macular edema. Ophthalmology. 1988;95:1335-1339. (Pubitemid 18240819)
20. Sebag J, Balazs EA. Pathogenesis of cystoid macular edema: an anatomic consideration of vitreoretinal adhesions. Surv Ophthalmol. 1984;28(suppl):493- 498. (Pubitemid 14076508)
21. Laidlaw DA. Vitrectomy for diabetic macular oedema. Eye. 2008;22:1337-1341.
22. Otani T, Kishi S. Tomographic findings of foveal hard exudates in diabetic macular edema. Am J Ophthalmol. 2001;131:50-54. (Pubitemid 32037008)
23. Soliman W, Sander B, Hasler PW, et al. Correlation between intraretinal changes in diabetic macular oedema seen in fluorescein angiography and optical coherence tomography. Acta Ophthalmol. 2008;86:34-39.
24. Otani T, Kishi S, Maruyama Y. Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol. 1999;127:688-693. (Pubitemid 29266745)
25. Kim BY, Smith SD, Kaiser PK. Optical coherence tomographic patterns of diabetic macular edema. Am J Ophthalmol. 2006;142:405-412.
26. Alkuraya H, Kangave D, Abu El-Asrar AM. The correlation between optical coherence tomographic features and severity of retinopathy, macular thickness and visual acuity in diabetic macular edema. Int Ophthalmol. 2005;26:93-99. (Pubitemid 44781874)
27. Otani T, Kishi S. Correlation between optical coherence tomography and fluorescein angiography findings in diabetic macular edema. Ophthalmology. 2007;114:104-107. (Pubitemid 46014295)
28. Brasil OF, Smith SD, Galor A, et al. Predictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography study. Br J Ophthalmol. 2007;91:761-765. (Pubitemid 46846647)
29. Gaucher D, Sebah C, Erginay A, et al. Optical coherence tomography features during the evolution of serous retinal detachment in patients with diabetic macular edema. Am J Ophthalmol. 2008;145:289-296.
30. Ozdemir H, Karacorlu M, Karacorlu SA. Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema. Am J Ophthalmol. 2005;140:251-255. (Pubitemid 41456576)
31. Gaucher D, Tadayoni R, Erginay A, et al. Optical coherence tomography assessment of the vitreoretinal relationship in diabetic macular edema. Am J Ophthalmol. 2005;139:807-813. (Pubitemid 40614765)
32. Thomas D, Bunce C, Moorman C, et al. Frequency and associations of a taut thickened posterior hyaloid, partial vitreomacular separation, and subretinal fluid in patients with diabetic macular edema. Retina. 2005;25:883-888. (Pubitemid 41456580)
33. Ghazi NG, Ciralsky JB, Shah SM, et al. Optical coherence tomography findings in persistent diabetic macular edema: the vitreomacular interface. Am J Ophthalmol. 2007;144:747-754.
34. Nussenblatt RB, Kaufman SC, Palestine AG, et al. Macular thickening and visual acuity. Measurement in patients with cystoid macular edema. Ophthalmology. 1987;94:1134-1139.
35. Strom C, Sander B, Larsen N, et al. Diabetic macular edema assessed with optical coherence tomography and stereo fundus photography. Invest Ophthalmol Vis Sci. 2002;43:241-245. (Pubitemid 34032465)
36. Hee MR, Puliafito CA, Duker JS, et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology. 1998;105:360-370. (Pubitemid 28090845)
37. Hee MR, Puliafito CA, Wong C, et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol. 1995;113:1019-1029.
38. Schuman JS, Puliafito CA, Fujimoto JG. Optical Coherence Tomography of Ocular Diseases. 2nd ed. Thorofare, NJ: Slack Inc.; 2004.
39. Browning DJ, Glassman AR, Aiello LP, et al, DRCR Network. Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology. 2008;115:1366-1371, 71.e1.
40. Glassman AR, Beck RW, Browning DJ, et al. Comparison of optical coherence tomography in diabetic macular edema, with and without reading center manual grading from a clinical trials perspective. Invest Ophthalmol Vis Sci. 2009;50:560-566.
41. Diabetic Retinopathy Clinical Research Network. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology. 2007;114:525-536. (Pubitemid 46282944)
42. Sadda SR, Wu Z, Walsh AC, et al. Errors in retinal thickness measurements obtained by optical coherence tomography. Ophthalmology. 2006;113:285-293. (Pubitemid 43170778)
43. Polito A, Del Borrello M, Isola M, et al. Repeatability and reproducibility of fast macular thickness mapping with stratus optical coherence tomography. Arch Ophthalmol. 2005;123:1330-1337. (Pubitemid 41429732)
44. Diabetic Retinopathy Clinical Research Network. Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology. 2007;114:1520-1525. (Pubitemid 47126582)
45. Massin P, Vicaut E, Haouchine B, et al. Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol. 2001;119:1135-1142. (Pubitemid 32729999)
46. Browning DJ, Fraser CM, Powers ME. Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application. Ophthalmology. 2006;113:1713-1719.
47. Avitabile T, Longo A, Reibaldi A. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. Am J Ophthalmol. 2005;140:695-702. (Pubitemid 41455312)
48. Sandhu SS, Birch MK, Griffiths PG, et al. Short-term effects of focal argon laser treatment in diabetic maculopathy as demonstrated by optical coherence tomography. Retina. 2007;27:13-20.
49. Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology. 2008;115:1447-1449, 9.e1-9.e10.
50. Diabetic Retinopathy Clinical Research Network. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol. 2007;125:469-480. (Pubitemid 46596718)
51. Ciardella AP, Klancnik J, SchiffW, et al. Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study. Br J Ophthalmol. 2004;88:1131-1136. (Pubitemid 39141371)
52. Karacorlu M, Ozdemir H, Karacorlu S, et al. Intravitreal triamcinolone as a primary therapy in diabetic macular oedema. Eye. 2005;19:382-386. (Pubitemid 40553136)
53. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology. 2002;109:920-927. (Pubitemid 34465226)
54. Massin P, Audren F, Haouchine B, et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology. 2004;111:218-224; discussion 224-225. (Pubitemid 38183217)
55. Patelli F, Fasolino G, Radice P, et al. Time course of changes in retinal thickness and visual acuity after intravitreal triamcinolone acetonide for diffuse diabetic macular edema with and without previous macular laser treatment. Retina. 2005;25:840-845. (Pubitemid 41456573)
56. Sutter FK, Simpson JM, Gillies MC. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology. 2004;111:2044-2049.
57. Jonas JB, Spandau UH, Kamppeter BA, et al. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema. Ophthalmology. 2006;113:800-804.
58. Kang SW, Sa HS, Cho HY, et al. Macular grid photocoagulation after intravitreal triamcinolone acetonide for diffuse diabetic macular edema. Arch Ophthalmol. 2006;124:653-658.
59. Lam DS, Chan CK, Mohamed S, et al. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: sixmonth outcomes. Ophthalmology. 2007;114:2162-2167. (Pubitemid 350181096)
60. Diabetic Retinopathy Clinical Research Network. Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study. Ophthalmology. 2007;114:1190-1196.
61. Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H, et al, Pan-American Collaborative Retina Study Group. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalology. 2007;114:743-750.
62. Chun DW, Heier JS, Topping TM, et al. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. Ophthalmology. 2006;113:1706-1712.
63. Macugen Diabetic Retinopathy Study. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology. 2005;112:1747-1757.
64. Diabetic Retinopathy Clinical Research Network. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology. 2007;114:1860-1867.
65. Paccola L, Costa RA, Folgosa MS, et al. Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study). Br J Ophthalmol. 2008;92:76-80.
66. Shimura M, Nakazawa T, Yasuda K, et al. Comparative Therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema. Am J Ophthalmol. 2008;145:845-861.
67. Lewis H, Abrams GW, Blumenkranz MS, et al. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology. 1992;99:753-759.
68. Otani T, Kishi S. Tomographic assessment of vitreous surgery for diabetic macular edema. Am J Ophthalmol. 2000;129:487-494. (Pubitemid 30184920)
69. Kumar A, Sinha S, Azad R, et al. Comparative evaluation of vitrectomy and dyeenhanced ILM peel with grid laser in diffuse diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2007;245:360-368. (Pubitemid 46403996)
70. Patel JI, Hykin PG, Schadt M, et al. Diabetic macular oedema: pilot randomised trial of pars plana vitrectomy versus macular argon photocoagulation. Eye. 2006;20:873-881. (Pubitemid 44210178)
71. Stolba U, Binder S, Gruber D, et al. Vitrectomy for persistent diffuse diabetic macular edema. Am J Ophthalmol. 2005;140:295-301. (Pubitemid 41125810)
72. Thomas D, Bunce C, Moorman C, et al. A randomised controlled feasibility trial of vitrectomy versus laser for diabetic macular oedema. Br J Ophthalmol. 2005;89:81-86. (Pubitemid 40040244)
73. Yanyali A, Horozoglu F, Celik E, et al. Pars plana vitrectomy and removal of the internal limiting membrane in diabetic macular edema unresponsive to grid laser photocoagulation. Eur J Ophthalmol. 2006;16:573-581. (Pubitemid 44859666)
74. Yanyali A, Nohutcu AF, Horozoglu F, et al. Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema. Am J Ophthalmol. 2005;139:795-801. (Pubitemid 40614763)
75. Massin P, Duguid G, Erginay A, et al. Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. Am J Ophthalmol. 2003;135:169-177. (Pubitemid 36151793)
76. Goebel W, Kretzchmar-Gross T. Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT). Retina. 2002;22:759-767. (Pubitemid 35462506)
77. Larsson J, Zhu M, Sutter F, et al. Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone. Am J Ophthalmol. 2005;139:802-806. (Pubitemid 40614764)
78. Imai M, Iijima H, Hanada N. Optical coherence tomography of tractional macular elevations in eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 2001;132:458-461. (Pubitemid 33732942)
79. Mirza RG, Johnson MW, Jampol LM. Optical coherence tomography use in evaluation of the vitreoretinal interface: a review. Surv Ophthalmol. 2007;52:397-421. (Pubitemid 46898548)
80. Brown JC, Solomon SD, Bressler SB, et al. Detection of diabetic foveal edema: contact lens biomicroscopy compared with optical coherence tomography. Arch Ophthalmol. 2004;122:330-335.
81. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology. 1998;105:1801-1815.
82. Browning DJ, Fraser CM, Clark S. The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema. Ophthalmology. 2008;115:533-539.e2.
83. Wojtkowski M, Bajraszewski T, Gorczyńska I, et al. Ophthalmic imaging by spectral optical coherence tomography. Am J Ophthalmol. 2004;138:412-419. (Pubitemid 39208568)
84. Sadda SR, Joeres S, Wu Z, et al. Error correction and quantitative subanalysis of optical coherence tomography data using computer-assisted grading. Invest Ophthalmol Vis Sci. 2007;48:839-848. (Pubitemid 351260721)
85. Barthelmes D, Sutter FK, Gillies MC. Differential optical densities of intraretinal spaces. Invest Ophthalmol Vis Sci. 2008;49:3529-3534.
86. Gibran SK, Khan K, Jungkim S, et al. Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edema. Ophthalmology. 2007;114:890-894. (Pubitemid 46656405)
87. Drexler W. Cellular and functional optical coherence tomography of the human retina: the Cogan lecture. Invest Ophthalmol Vis Sci. 2007;48:5339-5351. (Pubitemid 351260831)